Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,178 | 85 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $972.42 | 10 | $0 (2024) |
| Astellas Pharma US Inc | $500.36 | 5 | $0 (2019) |
| Sun Pharmaceutical Industries Inc. | $432.01 | 21 | $0 (2023) |
| PFIZER INC. | $387.78 | 11 | $0 (2020) |
| Galderma Laboratories, L.P. | $166.64 | 7 | $0 (2023) |
| EPI Health, LLC | $149.69 | 6 | $0 (2021) |
| AstraZeneca Pharmaceuticals LP | $78.17 | 1 | $0 (2018) |
| Incyte Corporation | $68.78 | 3 | $0 (2024) |
| Janssen Biotech, Inc. | $62.37 | 3 | $0 (2024) |
| Taro Pharmaceuticals USA, Inc. | $62.11 | 3 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $89.57 | 4 | Incyte Corporation ($41.64) |
| 2023 | $219.60 | 9 | Galderma Laboratories, L.P. ($76.98) |
| 2022 | $235.18 | 11 | Sun Pharmaceutical Industries Inc. ($142.44) |
| 2021 | $293.73 | 14 | SUN PHARMACEUTICAL INDUSTRIES INC. ($159.60) |
| 2020 | $428.60 | 9 | PFIZER INC. ($197.95) |
| 2019 | $553.24 | 12 | AbbVie, Inc. ($249.99) |
| 2018 | $830.75 | 18 | AbbVie, Inc. ($339.86) |
| 2017 | $526.96 | 8 | Astellas Pharma US Inc ($240.40) |
All Payment Transactions
85 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 08/29/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $15.39 | General |
| Category: Dermatology | ||||||
| 08/13/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $27.52 | General |
| Category: IMMUNOLOGY | ||||||
| 05/30/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $20.41 | General |
| Category: Immunology | ||||||
| 05/09/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $26.25 | General |
| Category: Dermatology | ||||||
| 10/24/2023 | LEO Pharma Inc. | ADBRY (Biological) | Food and Beverage | In-kind items and services | $17.59 | General |
| Category: DERMATOLOGY | ||||||
| 08/03/2023 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $23.32 | General |
| 07/13/2023 | Myriad Genetic Laboratories, Inc. | PROLARIS (Device) | Food and Beverage | In-kind items and services | $18.79 | General |
| Category: ONCOLOGY | ||||||
| 07/05/2023 | Sun Pharmaceutical Industries Inc. | Winlevi (Drug) | Food and Beverage | In-kind items and services | $30.32 | General |
| Category: Dermatology | ||||||
| 06/08/2023 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $22.33 | General |
| Category: Immunology | ||||||
| 04/20/2023 | Journey Medical Corporation | — | Food and Beverage | In-kind items and services | $27.72 | General |
| 03/09/2023 | Sun Pharmaceutical Industries Inc. | Winlevi (Drug) | Food and Beverage | In-kind items and services | $25.87 | General |
| Category: Dermatology | ||||||
| 03/08/2023 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $24.87 | General |
| 01/17/2023 | Galderma Laboratories, L.P. | AKLIEF (Drug), ORACEA, TWYNEO | Food and Beverage | In-kind items and services | $28.79 | General |
| Category: ACNE | ||||||
| 09/27/2022 | Sun Pharmaceutical Industries Inc. | Winlevi (Drug) | Food and Beverage | In-kind items and services | $31.47 | General |
| Category: Dermatology | ||||||
| 09/01/2022 | Journey Medical Corporation | QBREXZA (Drug), Accutane | Food and Beverage | In-kind items and services | $23.79 | General |
| Category: Dermatology | ||||||
| 08/04/2022 | Sun Pharmaceutical Industries Inc. | Winlevi (Drug) | Food and Beverage | In-kind items and services | $32.91 | General |
| Category: Dermatology | ||||||
| 07/26/2022 | Sun Pharmaceutical Industries Inc. | Winlevi (Drug) | Food and Beverage | In-kind items and services | $6.80 | General |
| Category: Dermatology | ||||||
| 06/28/2022 | Sun Pharmaceutical Industries Inc. | Winlevi (Drug) | Food and Beverage | In-kind items and services | $9.32 | General |
| Category: Dermatology | ||||||
| 05/19/2022 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $22.18 | General |
| 04/28/2022 | Sun Pharmaceutical Industries Inc. | Winlevi (Drug) | Food and Beverage | In-kind items and services | $24.28 | General |
| Category: Dermatology | ||||||
| 03/31/2022 | Sun Pharmaceutical Industries Inc. | Winlevi (Drug) | Food and Beverage | In-kind items and services | $15.78 | General |
| Category: Dermatology | ||||||
| 03/02/2022 | Janssen Biotech, Inc. | REMICADE (Biological), SIMPONI, SIMPONI ARIA | Food and Beverage | In-kind items and services | $19.63 | General |
| Category: Immunology | ||||||
| 02/08/2022 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $27.14 | General |
| Category: Dermatology | ||||||
| 01/05/2022 | Sun Pharmaceutical Industries Inc. | Winlevi (Drug) | Food and Beverage | In-kind items and services | $21.88 | General |
| Category: Dermatology | ||||||
| 12/14/2021 | SUN PHARMACEUTICAL INDUSTRIES INC. | Winlevi (Drug) | Food and Beverage | In-kind items and services | $6.90 | General |
| Category: Dermatology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 846 | 1,823 | $170,875 | $103,647 |
| 2022 | 10 | 890 | 1,631 | $155,785 | $91,446 |
| 2021 | 10 | 867 | 1,563 | $151,370 | $92,269 |
| 2020 | 10 | 695 | 1,186 | $113,930 | $60,851 |
All Medicare Procedures & Services
40 procedure records from CMS Medicare Utilization — Page 2 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 81000 | Manual urinalysis test with examination using microscope, non-automated | Office | 2021 | 252 | 559 | $11,180 | $2,247 | 20.1% |
| 53660 | Dilation of bladder canal (urethra), female, initial | Office | 2021 | 27 | 27 | $4,050 | $1,861 | 45.9% |
| 87210 | Smear for infectious agents | Office | 2021 | 126 | 264 | $5,280 | $1,536 | 29.1% |
| 51701 | Insertion of temporary bladder catheter | Office | 2021 | 14 | 16 | $1,600 | $663.68 | 41.5% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2021 | 18 | 23 | $560.00 | $69.00 | 12.3% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 137 | 206 | $41,500 | $23,756 | 57.2% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 97 | 172 | $21,575 | $15,460 | 71.7% |
| 99205 | New patient office or other outpatient visit, typically 60 minutes | Office | 2020 | 57 | 57 | $19,950 | $9,524 | 47.7% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 22 | 24 | $8,300 | $4,189 | 50.5% |
| 53661 | Dilation of bladder canal (urethra), female | Office | 2020 | 32 | 54 | $5,400 | $3,280 | 60.7% |
| 81000 | Manual urinalysis test with examination using microscope | Office | 2020 | 205 | 439 | $8,780 | $1,757 | 20.0% |
| 87210 | Smear for infectious agents | Office | 2020 | 95 | 179 | $3,580 | $1,037 | 29.0% |
| 53660 | Dilation of bladder canal (urethra), female | Office | 2020 | 14 | 14 | $2,100 | $904.18 | 43.1% |
| 51701 | Insertion of temporary bladder catheter | Office | 2020 | 19 | 23 | $2,300 | $889.89 | 38.7% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2020 | 17 | 18 | $445.00 | $53.58 | 12.0% |
About Dr. Kiumars Bakshandeh, M.D
Dr. Kiumars Bakshandeh, M.D is a Specialist healthcare provider based in Beverly Hills, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/08/2006. The National Provider Identifier (NPI) number assigned to this provider is 1700945144.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Kiumars Bakshandeh, M.D has received a total of $3,178 in payments from pharmaceutical and medical device companies, with $89.57 received in 2024. These payments were reported across 85 transactions from 22 companies. The most common payment nature is "Food and Beverage" ($3,178).
As a Medicare-enrolled provider, Bakshandeh has provided services to 3,298 Medicare beneficiaries, totaling 6,203 services with total Medicare billing of $348,213. Data is available for 4 years (2020–2023), covering 40 distinct procedure/service records.
Practice Information
- Specialty Specialist
- Location Beverly Hills, CA
- Active Since 12/08/2006
- Last Updated 07/09/2007
- Taxonomy Code 174400000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1700945144
Products in Payments
- XTANDI (Drug) $571.31
- Lupron (Drug) $443.27
- Lupron Depot (Drug) $249.99
- Winlevi (Drug) $248.99
- Xtandi (Drug) $240.40
- LUPRON DEPOT (Drug) $149.90
- Sitavig (Drug) $130.97
- Absorica LD (Drug) $109.24
- Androgel (Drug) $101.74
- FARXIGA (Drug) $78.17
- TOVIAZ (Drug) $76.43
- OPZELURA (Drug) $68.78
- ULTRAVATE (halobetasol propionate) lotion (Drug) $43.70
- TREMFYA (Drug) $42.74
- ENSTILAR (Drug) $41.50
- ABSORICA LD (Drug) $39.41
- QBREXZA (Drug) $35.04
- AKLIEF (Drug) $28.79
- RINVOQ (Biological) $27.52
- Acticlate (Drug) $23.58
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Specialist Doctors in Beverly Hills
Dr. Norman Lepor, M.d, M.D
Specialist — Payments: $3.0M
Dr. Michael Bush, M.d, M.D
Specialist — Payments: $614,437
Dr. Stuart Silverman, Md, MD
Specialist — Payments: $572,532
Dr. Suzanne Gilberg-Lenz, M.d, M.D
Specialist — Payments: $319,119
Dr. Todd Lanman, M.d., F.a.c.s, M.D., F.A.C.S
Specialist — Payments: $308,676
Dr. Hooman Melamed, M.d, M.D
Specialist — Payments: $202,585